High materiality7/10
COAG Hemab Therapeutics price target raised to $64 from $55 at Wedbush
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wedbush raises COAG target to $64 (from $55); current price $51.77; price change since signal +3.31.
- Wedbush raises COAG PT to $64; price $51.77; +3.31 since signal.
Key facts
- 01
Target: $64
- 02
Posted price: $51.77
- 03
Analyst firm: Wedbush
- 04
Analyst: David Nierengarten
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.